Skip to content
Clinical Trials – home
PolandBack to Poland

Clinical trials in Nowa Sol

83 clinical trials in Nowa Sol, Poland across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

PolandOur site in PolandBadaniaKliniczne.pl(opens in a new tab)
Nowa Sol at a glance
83
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

83 trials in Nowa Sol

Open in trial search
Countries:PolandPoland
  • Participants:18–64 years
  • Sponsor:Zenas Biopharma (USA) LLC

Phase 2 Study of Nemolizumab for Skin Thickening in Adults with Systemic Sclerosis

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Nemolizumab
  • Sponsor:Galderma S.A.

Evaluation of Anifrolumab Subcutaneous Treatment in Immunosuppressant‑Naïve and Biologic‑Naïve Patients with Systemic Lupus Erythematosus

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Anifrolumab
  • Sponsor:AstraZeneca AB

Orelabrutinib in Patients with Primary Progressive Multiple Sclerosis

Investigational
Countries:PolandPoland
  • Participants:18–64 years
  • Sponsor:Zenas Biopharma (USA) LLC

Long-Term Safety and Efficacy of Zasocitinib in Adults with Active Psoriatic Arthritis

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Zasocitinib
  • Sponsor:Takeda Development Center Americas Inc.

Alopecia areata

Recruiting

A study to evaluate the effectiveness and safety of LAD603 in adults with severe to very severe alopecia areata

Investigational
Countries:PolandPoland
  • Participants:18–64 years
  • Sponsor:Almirall S.A.

A study to evaluate the long-term safety and effectiveness of barzolvolimab in patients with chronic spontaneous urticaria

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Barzolvolimab
  • Sponsor:Celldex Therapeutics Inc.

Vitiligo

Recruiting

Study of ruxolitinib cream for children aged 6 to 12 years with non-segmental vitiligo

Investigational
Countries:PolandPoland
  • Participants:0–17 years
  • Substances:Ruxolitinib
  • Sponsor:Incyte Corp.

Study of Zasocitinib and Apremilast for Adults with Active Psoriatic Arthritis Who Have Not Used Biologic Medicines

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Apremilast
  • Sponsor:Takeda Development Center Americas Inc.

Study on the Safety of BHV-7000 for Adults with Hard-to-Treat Focal Onset Epilepsy

InvestigationalNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:BHV-7000
  • Sponsor:Biohaven Therapeutics Ltd.

Study on the Effectiveness of Abelacimab for High-Risk Atrial Fibrillation Patients Unsuitable for Oral Anticoagulation

Investigational
Countries:PolandPoland
  • Participants:65+ years
  • Substances:Abelacimab
  • Sponsor:Anthos Therapeutics Inc.

Asthma

Recruiting

Study of Three Doses of Frevecitinib (KN-002) in Adults with Severe Asthma Not Controlled by Medium‑to‑High Dose Inhaled Steroid/LABA Therapy

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Salbutamol Sulfate

Other cities in Poland

The busiest research cities in the country

All 239 cities in Poland

Clinical research in Nowa Sol

What the registry says about research in the country

01 Rheumatology Studies

Innovative research focusing on psoriatic arthritis and rheumatoid arthritis treatments, evaluating new biological therapies and biosimilars for improved patient outcomes.

  • Zasocitinib for psoriatic arthritis
  • Tocilizumab biosimilar studies
  • Rosnilimab efficacy trials

Multiple studies are investigating novel therapeutic approaches for patients who haven't responded to conventional treatments.

02 Dermatological Conditions

Comprehensive research into atopic dermatitis and plaque psoriasis, including studies for both adult and pediatric populations.

  • Bimekizumab for plaque psoriasis
  • Lunsekimig for atopic dermatitis
  • ADX-914 clinical evaluation

These trials aim to advance treatment options for moderate to severe skin conditions.

03 Autoimmune Disorders

Groundbreaking research in Sjögren's Syndrome and systemic lupus erythematosus, testing novel therapeutic approaches.

  • Dazodalibep safety studies
  • Anifrolumab subcutaneous administration
  • Systemic sclerosis treatments

Focus on developing targeted therapies for complex autoimmune conditions.

04 Neurological Research

Studies addressing epilepsy and Alzheimer's-related conditions, including innovative treatment approaches for seizure management.

  • XEN1101 for seizure control
  • Alzheimer's agitation treatment
  • Staccato alprazolam evaluation

Research aims to improve quality of life for patients with neurological disorders.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.